Riskpilot← Back to searchSign inGet full accessDOCTRIVET AB
ABActiveOrg 5568974876Römossevägen 29Veterinary activities · NACE 7500Est. 201210-19 employees
Revenue 2025
SEK 10,6M
+5% vs 2024
EBITDA margin
6.2%
+177% vs 2024
Equity ratio
12.2%
Financial strength
Net profit 2025
SEK 457K
+146% vs 2024
| Revenue | SEK 10,6M | +5% |
| EBITDA | SEK 656K | +177% |
| Net profit | SEK 457K | +146% |
| Total assets | SEK 2,5M | +46% |
| Equity | SEK 307K | +271% |
| Employees | — | — |
Legal name
DOCTRIVET AB
Org number
5568974876
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
2 juli 2012
Share capital
SEK 300 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva veterinärklinik för smådjur samt därmed förenlig verksamhet.
Address
Römossevägen 29
Phone
+46739604045
Email
raadaskar@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 7 120 | 7 192 | 9 495 | 10 880 | 10 254 | 10 116 | 10 064 | 10 605 |
| Staff expenses | — | — | — | — | — | — | — | −4 980 | −4 167 | — | −5 383 |
| EBITDA | 258 | 598 | 272 | 240 | 253 | 781 | 584 | 338 | 936 | −857 | 656 |
| Depreciation & amort. | −95 | −138 | −154 | −106 | −133 | −306 | −226 | −265 | −311 | −280 | −145 |
| EBIT | 163 | 460 | 118 | 134 | 120 | 475 | 358 | 73 | 624 | −1 137 | 510 |
| Net financials | −18 | −11 | −11 | −10 | −20 | −29 | −23 | −19 | −16 | −18 | −53 |
| Profit before tax | 145 | 449 | 107 | 124 | 99 | 345 | 336 | 154 | 448 | −995 | 457 |
| Tax | −0 | −0 | −0 | −0 | −0 | −72 | −85 | −45 | −100 | −0 | — |
| Net profit | 145 | 449 | 107 | 124 | 99 | 273 | 251 | 109 | 348 | −995 | 457 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 153 | 1 441 | 1 306 | 1 423 | 1 836 | 2 403 | 2 346 | 1 753 | 2 065 | 1 720 | 2 510 |
| Equity | 296 | 744 | 411 | 435 | 434 | 607 | 708 | 547 | 815 | −180 | 307 |
| Long-term debt | 448 | 0 | 74 | 0 | 0 | 0 | 0 | — | — | 0 | 49 |
| Short-term debt | 409 | 697 | 821 | 988 | 1 402 | 1 696 | 1 538 | 1 206 | 1 090 | 1 900 | 2 154 |
| Total debt | 857 | 697 | 895 | 988 | 1 402 | 1 696 | 1 538 | 1 206 | 1 090 | 1 900 | 2 203 |
EBITDA margin
6.2%
This company
15.8%
Market median
-61% vs market
20152025
Equity ratio
12.2%
This company
38.2%
Market median
-68% vs market
20152025
Return on equity
148.8%
This company
18.4%
Market median
+709% vs market
20152025
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20152025
Asset turnover
4.23×
This company
1.12×
Market median
+278% vs market
20152025
Debt / equity
7.17×
This company
0.62×
Market median
-1056% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AM Audit | Audit | 2022 | — | — |
PE Chief Auditor | Chief Auditor | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DOCTRIVET AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Raad Adel Yacoub Askar | Chief Executive Officer | 0 companies |
| Anna Maria Kraft | Audit | 0 companies |
| Petter Erik Gustafsson | Chief Auditor | 0 companies |
| Tania Marie Randquist | Board of Directors | 0 companies |